Electrospinning Optimization of Eudragit e PO with and without Chlorpheniramine Maleate Using a Design of Experiment Approach

Hend E. Abdelhakim, Alastair Coupe, Catherine Tuleu, Mohan Edirisinghe, Duncan Q.M. Craig

Research output: Contribution to journalArticlepeer-review

40 Citations (SciVal)

Abstract

Electrospinning is increasingly becoming a viable means of producing drug delivery vehicles for oral delivery, particularly as issues of manufacturing scalability are being addressed. In this study, electrospinning is explored as a taste-masking manufacturing technology for bitter drugs. The taste-masking polymer Eudragit E PO (E-EPO) was electrospun, guided by a quality by design approach. Using a design of experiment, factors influencing the production of smooth fibers were investigated. Polymer concentration, solvent composition, applied voltage, flow rate, and gap distance were the parameters examined. Of these, polymer concentration was shown to be the only statistically significant factor within the ranges studied (p-value = 0.0042). As the concentration increased, smoother fibers were formed, coupled with an increase in fiber diameter. E-EPO (35% w/v) was identified as the optimum concentration for smooth fiber production. The optimized processing conditions identified were a gap distance of 175 mm, an applied voltage of between 15 and 20 kV, and a flow rate of 1 mL/h. Using this knowledge, the production optimization of electrospun E-EPO with chlorpheniramine maleate (CPM), a bitter antihistamine drug, was explored. The addition of CPM in drug loads of 1:6 up to 1:10 CPM/E-EPO yielded smooth fibers that were electrospun under conditions similar to placebo fibers. Solid-state characterization showed CPM to be molecularly dispersed in E-EPO. An electronic tasting system, or E-tongue, indicated good taste-masking performance as compared to the equivalent physical mixtures. This study therefore describes a means of producing, optimizing, and assessing the performance of electrospun taste-masked fibers as a novel approach to the formulation of CPM and potentially other bitter drug substances.

Original languageEnglish
Pages (from-to)2557-2568
Number of pages12
JournalMolecular Pharmaceutics
Volume16
Issue number6
Early online date25 Apr 2019
DOIs
Publication statusPublished - 3 Jun 2019

Funding

This work was financially supported by the Medical Research Council, London, UK; iCASE award no. 170156 and Pfizer Ltd, Sandwich, UK; award no. 173803. The authors would like to thank Dr. Andrew Weston for his help with SEM imaging.

Keywords

  • chlorpheniramine maleate
  • DoE
  • E-tongue
  • electrospinning
  • Eudragit E PO
  • taste-masking

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Electrospinning Optimization of Eudragit e PO with and without Chlorpheniramine Maleate Using a Design of Experiment Approach'. Together they form a unique fingerprint.

Cite this